9999999997-17-001536.txt : 20170302 9999999997-17-001536.hdr.sgml : 20170302 20170302135843 ACCESSION NUMBER: 9999999997-17-001536 CONFORMED SUBMISSION TYPE: CT ORDER PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20170302 DATE AS OF CHANGE: 20170302 20170302 20170302 FILER: COMPANY DATA: COMPANY CONFORMED NAME: AGENUS INC CENTRAL INDEX KEY: 0001098972 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 061562417 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CT ORDER SEC ACT: 1934 Act SEC FILE NUMBER: 000-29089 FILM NUMBER: 17658045 BUSINESS ADDRESS: STREET 1: 3 FORBES ROAD CITY: LEXINGTON STATE: MA ZIP: 02421 BUSINESS PHONE: 781-674-4410 MAIL ADDRESS: STREET 1: 3 FORBES ROAD CITY: LEXINGTON STATE: MA ZIP: 02421 FORMER COMPANY: FORMER CONFORMED NAME: ANTIGENICS INC /DE/ DATE OF NAME CHANGE: 19991115 CT ORDER 1 filename1.pdf begin 644 filename1.pdf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